Kenvue shares fell over 7% to a record low during Monday's session ahead of an announcement at the White House. The stock climbed in after-hours trading. Tylenol maker Kenvue said that scientific studies showed that there was no link between acetaminophen and autism. Justin Sullivan / Getty Images Close KEY TAKEAWAYS Shares of Tylenol maker Kenvue (KVUE) dropped Monday ahead of an anticipated report by the Trump administration linking pregnant women's use of the painkiller to autism. Investopedia requires w ...